Nootropics

Armodafinil

Evidence: strong_human

Mechanism of Action

The isolated R-enantiomer of racemic modafinil, sharing the same primary mechanism — selective inhibition of the dopamine transporter (DAT) — but with distinct pharmacokinetics. The R-enantiomer has a terminal half-life of ~15 hours vs. ~4-5 hours for the S-enantiomer, resulting in 33-40% higher plasma AUC compared to equimolar racemic modafinil. This translates to more sustained wakefulness-promoting activity throughout the day. Same downstream activation of orexinergic, histaminergic, and noradrenergic pathways as modafinil.

Dosing Protocol

Standard: 75-150 mg once daily (for educational context only — prescription medication in most jurisdictions)

Maintenance: 75-150 mg/day; 150 mg is the most common clinical dose

Administration: oral

Timing: Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours.

Duration: Same as modafinil; not typically cycled in clinical use.

Notes

FOR EDUCATIONAL PURPOSES ONLY — Armodafinil is a prescription medication. The practical advantage over modafinil is more sustained late-day plasma levels without the S-enantiomer's early peak and crash. At equimolar doses, armodafinil maintains higher plasma concentrations at 6-14 hours post-dose, making it preferable for shift workers or those needing all-day wakefulness. However, the longer effective duration increases insomnia risk if dosed too late. 150 mg armodafinil is roughly equivalent to 200 mg modafinil in clinical effect. Some users find armodafinil 'cleaner' and less anxiety-inducing than racemic modafinil, though this is subjective.

Stacking

  • L-Theanine
  • Alpha-GPC
  • Magnesium

Interactions

  • Hormonal contraceptives [HIGH] — CYP3A4 induction reduces efficacy of oral contraceptives — same concern as modafinil
  • Cyclosporine [HIGH] — CYP3A4 induction reduces cyclosporine levels
  • CYP2C19 substrates [MEDIUM] — Inhibition of CYP2C19 may elevate levels of omeprazole, diazepam, phenytoin
  • Warfarin [MEDIUM] — Monitor INR closely

Contraindications

  • Same as modafinil: mitral valve prolapse, left ventricular hypertrophy, severe hepatic impairment, severe anxiety/psychotic disorders, hypersensitivity, pregnancy

Side Effects

  • Headache
  • Nausea
  • Dizziness
  • Insomnia (more pronounced than modafinil due to longer half-life)
  • Anxiety
  • Dry mouth
  • Diarrhea
  • Stevens-Johnson syndrome (very rare)

Key Papers

  • 10.1517/17425250903084942
  • 10.1016/j.clinthera.2010.11.012
  • 10.1016/j.sleep.2011.11.010

Source Quality

Prescription medication (Schedule IV in the US). Brand name Nuvigil (Cephalon/Teva). Also available as Waklert (Sun Pharma) and Artvigil (HAB Pharma). Same sourcing caveats as modafinil — pharmaceutical-grade only.

Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.

Should Armodafinil Be in Your Stack?

Take the free assessment and get personalized recommendations based on your biology and goals.

Get Your Free Protocolor take the assessment →
← Browse All 231 Compounds